These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chances and shortcomins of adenovirus-mediated ATP7B gene transfer in Wilson disease: proof of principle demonstrated in a pilot study with LEC rats. Ha-Hao D, Merle U, Hofmann C, Wesch H, Doll J, Auburger G, Tuma S, Strauss M, Stremmel W. Z Gastroenterol; 2002 Apr; 40(4):209-16. PubMed ID: 11961729 [Abstract] [Full Text] [Related]
8. Modifying factors and phenotypic diversity in Wilson's disease. Lutsenko S. Ann N Y Acad Sci; 2014 May; 1315():56-63. PubMed ID: 24702697 [Abstract] [Full Text] [Related]
9. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease. Boaru SG, Merle U, Uerlings R, Zimmermann A, Flechtenmacher C, Willheim C, Eder E, Ferenci P, Stremmel W, Weiskirchen R. J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483 [Abstract] [Full Text] [Related]
10. Restoration of copper metabolism and rescue of hepatic abnormalities in LEC rats, an animal model of Wilson disease, by expression of human ATP7B gene. Meng Y, Miyoshi I, Hirabayashi M, Su M, Mototani Y, Okamura T, Terada K, Ueda M, Enomoto K, Sugiyama T, Kasai N. Biochim Biophys Acta; 2004 Nov 05; 1690(3):208-19. PubMed ID: 15511628 [Abstract] [Full Text] [Related]
11. A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease. Greig JA, Nordin JML, Smith MK, Ashley SN, Draper C, Zhu Y, Bell P, Buza EL, Wilson JM. Hum Gene Ther Clin Dev; 2019 Mar 05; 30(1):29-39. PubMed ID: 30693797 [Abstract] [Full Text] [Related]
13. [Wilson's disease in paediatric age: diagnosis and treatment. Recent advances]. Palumbo E. Recenti Prog Med; 2008 Nov 05; 99(11):561-4. PubMed ID: 19209540 [Abstract] [Full Text] [Related]
14. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. de Bie P, van de Sluis B, Burstein E, van de Berghe PV, Muller P, Berger R, Gitlin JD, Wijmenga C, Klomp LW. Gastroenterology; 2007 Oct 05; 133(4):1316-26. PubMed ID: 17919502 [Abstract] [Full Text] [Related]
15. Hepatocyte transplantation in the Long Evans Cinnamon rat model of Wilson's disease. Park SM, Vo K, Lallier M, Cloutier AS, Brochu P, Alvarez F, Martin SR. Cell Transplant; 2006 Oct 05; 15(1):13-22. PubMed ID: 16700326 [Abstract] [Full Text] [Related]
16. Cell therapy to remove excess copper in Wilson's disease. Gupta S. Ann N Y Acad Sci; 2014 May 05; 1315(1):70-80. PubMed ID: 24820353 [Abstract] [Full Text] [Related]
17. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Gromadzka G, Schmidt HH, Genschel J, Bochow B, Rodo M, Tarnacka B, Litwin T, Chabik G, Członkowska A. Clin Genet; 2005 Dec 05; 68(6):524-32. PubMed ID: 16283883 [Abstract] [Full Text] [Related]
18. A systems approach implicates nuclear receptor targeting in the Atp7b(-/-) mouse model of Wilson's disease. Wilmarth PA, Short KK, Fiehn O, Lutsenko S, David LL, Burkhead JL. Metallomics; 2012 Jul 05; 4(7):660-8. PubMed ID: 22565294 [Abstract] [Full Text] [Related]
19. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Merle U, Schaefer M, Ferenci P, Stremmel W. Gut; 2007 Jan 05; 56(1):115-20. PubMed ID: 16709660 [Abstract] [Full Text] [Related]
20. Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load. Gray LW, Peng F, Molloy SA, Pendyala VS, Muchenditsi A, Muzik O, Lee J, Kaplan JH, Lutsenko S. PLoS One; 2012 Jan 05; 7(6):e38327. PubMed ID: 22802922 [Abstract] [Full Text] [Related] Page: [Next] [New Search]